CAAS Capital Management’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-232,796
| Closed | -$13.3M | – | 764 |
|
|
2021
Q1 | $13.3M | Buy |
232,796
+52,333
| +29% | +$2.99M | 0.14% | 64 |
|
|
2020
Q4 | $15.1M | Sell |
180,463
-877,908
| -83% | -$73.5M | 0.14% | 52 |
|
|
2020
Q3 | $37.9M | Sell |
1,058,371
-498,537
| -32% | -$17.9M | 0.88% | 9 |
|
|
2020
Q2 | $37.6M | Buy |
1,556,908
+524,881
| +51% | +$12.7M | 1.24% | 18 |
|
|
2020
Q1 | $18.1M | Buy |
+1,032,027
| New | +$18.1M | 1.89% | 5 |
|